Platelet Rich Plasma Prep System for Hypotrichosis

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Hypotrichosis+1 More
Platelet Rich Plasma Prep System - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is to test whether autologous platelet-rich plasma can help treat eyebrow hypotrichosis, or insufficient eyebrow hair growth. 40 people will be randomly chosen to either receive the plasma injections or a placebo saline solution. The trial will last 9 months.

Eligible Conditions
  • Hypotrichosis
  • Eyebrow structure

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Baseline to 6 months

Baseline to 6 months
Clinical change of eyebrow hypotrichosis, as determined by scoring photographs

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

2 Treatment Groups

Platelet-Rich Plasma
1 of 2
Placebo (sterile saline)
1 of 2
Experimental Treatment
Non-Treatment Group

30 Total Participants · 2 Treatment Groups

Primary Treatment: Platelet Rich Plasma Prep System · Has Placebo Group · Phase 2

Platelet-Rich Plasma
Device
Experimental Group · 1 Intervention: Platelet Rich Plasma Prep System · Intervention Types: Device
Placebo (sterile saline)
Drug
PlaceboComparator Group · 1 Intervention: Saline · Intervention Types: Drug

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 6 months

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,432 Previous Clinical Trials
769,507 Total Patients Enrolled
Murad AlamPrincipal Investigator - Northwestern University
Northwestern Memorial Hospital
Yale University School Of Medicine (Medical School)
Ny And Presby Hospital (Residency)

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
People aged 18 to 85 years old, who are either male or female.
Subjects appear to be in good health, as judged by the investigator.
People with mild to moderate eyebrow hair loss (modified GEyA grades of 3 and 4 at the time of screening, see Appendix A).
People who have less eyebrows and want to improve their eyebrows.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 18th, 2021

Last Reviewed: October 25th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.